Cryo-Cell International, Inc. Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

Description of Business, Basis of Presentation and Significant Accounting Policies - Additional Information (Detail)

Description of Business, Basis of Presentation and Significant Accounting Policies - Additional Information (Detail)			1 Months Ended	3 Months Ended		6 Months Ended
	Jun. 01, 2017 USD ($)	Feb. 01, 2012 USD ($)	Dec. 31, 2005 USD ($)	May 31, 2026 USD ($)	May 31, 2025 USD ($)	May 31, 2026 USD ($) Unit Segment	May 31, 2025 USD ($)
Business, Basis of Presentation and Significant Accounting Policies [Line Items]
Number of reportable segments \| Segment						3
Deferred revenue				$ 62,767,907		$ 62,767,907
Warranty payment	$ 100,000	$ 75,000	$ 50,000
Offset personal expenses	10,000
Commission paid				6,375	$ 9,132	13,619	$ 18,483
Additional capitalized contract acquisition costs, net of amortization expense				29,789	29,391	60,875	60,841
Impairment of contract assets				0	0	0	0
Uncertain tax provisions				0		0
Provisions for interest or penalties related to uncertain tax positions						0	0
Impairment on long lived assets				0	0	0	0
Stock-based option compensation expense				64,000	40,000	223,000	337,000
Unrealized holding (losses) gains, marketable securities				72,019	(379,332)	(168,439)	(410,733)
Payment warranty			$ 50,000
Increased payment warranty	$ 100,000	$ 75,000
Other Nonoperating Income (Expense) [Member]
Business, Basis of Presentation and Significant Accounting Policies [Line Items]
Unrealized holding (losses) gains, marketable securities				$ 72,000	$ (380,000)	$ (168,000)	$ (411,000)
Duke University [Member]
Business, Basis of Presentation and Significant Accounting Policies [Line Items]
Contracted storage amortization period				16 years		16 years
Umbilical Cord Blood and Cord Tissue Stem Cell Service and PrepaCyte-CB [Member] \| Duke University [Member]
Business, Basis of Presentation and Significant Accounting Policies [Line Items]
Inventory, in units \| Unit						6,000
Number of units, per month \| Unit						36
Maximum [Member] \| Umbilical Cord Blood and Cord Tissue Stem Cell Service and PrepaCyte-CB [Member] \| Duke University [Member]
Business, Basis of Presentation and Significant Accounting Policies [Line Items]
Inventory, in units \| Unit						36
Accounts Receivables [Member]
Business, Basis of Presentation and Significant Accounting Policies [Line Items]
Period of doubtful for accounts receivable due from client						30 days
Option One [Member]
Business, Basis of Presentation and Significant Accounting Policies [Line Items]
Contracted storage amortization period				1 year		1 year
Option Two [Member]
Business, Basis of Presentation and Significant Accounting Policies [Line Items]
Contracted storage amortization period				21 years		21 years
Option Three [Member]
Business, Basis of Presentation and Significant Accounting Policies [Line Items]
Contracted storage amortization period						life-time
Contracted storage amortization description						The life-time storage plan is based on a life expectancy of 81 years, which is the current estimate by the Center for Disease Control for United States women’s life expectancy and the Company concluded that additional data analysis would result in an immaterial difference in revenue recognition.